1.MMP9 and ADNP Gene Expressions in Secondary Bone Metastasis of Locally Advanced Nasopharyngeal Cancer
Rahmat Cahyanur ; Cosphiadi Irawan ; Lisnawati Rachmadi ; Marlinda Adham ; Achmad Fauzi Kamal ; Achmad Rusdan Handoyo Utomo ; Mardiah Suci Hardianti ; Thariqah Salamah ; Muchtaruddin Mansyur
Acta Medica Indonesiana 2026;58(1):59-66
Abstract
Background: Nasopharyngeal cancer (NPC) is a malignancy of the nasopharyngeal mucosal epithelium. Primary and secondary metastases in nasopharyngeal cancer are generally prevalent in the bones. Gene expression plays a critical role in regulating fundamental cellular processes in cancer cells, including metastasis. Methods: A total of 29 patients with non-metastatic NPC were included in the study. Results: The mean age of the participants was 48.45±9.98 years old. Most participants were male (75.9%). More than half of the participants had T4 and N2, 52.7% and 51.0% respectively). Secondary metastasis was observed in 9 of the 29 participants within two years. Patients with secondary metastases had a higher proportion of T4 (7/9) and N2 (4/9) disease. Bone was the first site of secondary metastasis (6/9 patients). The median time to secondary bone metastasis was 14.0 (6.8-21.2) months. Based on the differential expression gene (DEG) analysis, the MMP9 gene was upregulated 12.50 (4.18–37.40), adjusted p <0.01, and the ADNP gene was downregulated 0.141 (0.04–0.43), adjusted p 0.04, among patients with secondary bone metastasis. Conclusion: Bones are the first site of metastasis, with a time to metastasis of 14.0 (6.8-21,2) months. MMP9 was upregulated, and ANDP was downregulated in patients with bone metastasis compared to those without metastasis.
MMP-9
;
ADNP
;
nasopharyngeal cancer
;
secondary bone metastasis
2.Trauma Team Activation in the Emergency Department: A Literature Review of Criteria, Processes and Outcomes
Siti Nurlaelah ; Achmad Fauzi Kamal ; Dewi Irawati ; Muchtaruddin Mansyur ; Saptawati Bardosono
Malaysian Journal of Medicine and Health Sciences 2024;20(No.1):323-329
Multiple traumas require a fast and comprehensive treatment to overcome challenges that emerge from the patient’s
condition. The right time for trauma team activation is necessary to treat these multiple trauma patients to improve
patient outcomes. This integrative review identifies the criteria used to activate the trauma team, the activation process and the outcome of the activation. The search was conducted from January to March 2023 with two databases,
namely MEDLINE and PubMed, and grey literature via Google Scholar. The search was limited to articles written
in English, with abstracts and available in full text. There was no year limitation. The review found four criteria that
were used for trauma team activation: physiological, anatomical, mechanism of injury and others. The process of
trauma team activation begins in the pre-hospital setting. Outcomes used to evaluate the impact of trauma team activation included the level of satisfaction of patients and families, the level of complaints, response time, discharge
status, and mortality. The findings of this review recommend that the criteria, process, and outcomes of trauma team
activation are tailored, based on the needs and available resources of the institutions. Moreover, standardized trauma
team activation may be necessary for future development.


Result Analysis
Print
Save
E-mail